CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION

被引：0
|
作者：
BRENNER, MK
GRIFFITHS, PD
PRENTICE, HG
机构：
[1] ROYAL FREE HOSP,DEPT VIROL,LONDON NW3 2QG,ENGLAND
[2] ROYAL FREE HOSP,BONE MARROW TRANSPLANTAT PROGRAMME,LONDON NW3 2QG,ENGLAND
来源：
LANCET | 1987年 / 2卷 / 8553期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [21] DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE IN PNEUMONITIS OCCURRING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CORDONNIER, C
    BERNAUDIN, JF
    FLEURY, J
    FEUILHADE, M
    HAIOUN, C
    PAYEN, D
    HUET, Y
    ATASSI, K
    VERNANT, JP
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 132 (05): : 1118 - 1123
  • [22] DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV) PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SCHROEDER, M
    ESSELL, J
    HARMAN, G
    HALVORSON, R
    DOLAN, M
    CALLANDER, N
    SNYDER, M
    WILKS, S
    ALLERTON, J
    THOMPSON, J
    BLOOD, 1993, 82 (10) : A425 - A425
  • [23] PROPHYLAXIS OF CYTOMEGALOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GRIGG, A
    PHILLIPS, G
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05): : 972 - 972
  • [24] PROPHYLAXIS OF CYTOMEGALOVIRUS-INFECTION WITH GANCICLOVIR IN ALLOGENEIC MARROW TRANSPLANTATION
    YAU, JC
    DIMOPOULOS, MA
    HUAN, SD
    TARRAND, JJ
    SPENCER, V
    SPITZER, G
    MENEGHETTI, CM
    WALLERSTEIN, RO
    ANDERSSON, BS
    LEMAISTRE, CF
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (05) : 371 - 376
  • [25] CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
    许晓华
    黄连生
    张晓红
    朱康儿
    徐炀
    吴东
    赵小英
    ChineseJournalofCancerResearch, 2005, (04) : 294 - 297
  • [26] CYTOMEGALOVIRUS ANTIGEN-DETECTION IN PERIPHERAL-BLOOD LEUKOCYTES AFTER ALLOGENEIC MARROW TRANSPLANTATION
    BOECKH, M
    BOWDEN, RA
    GOODRICH, JM
    PETTINGER, M
    MEYERS, JD
    BLOOD, 1992, 80 (05) : 1358 - 1364
  • [27] Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation
    Szer, J
    Durrant, S
    Schwarer, AP
    Bradstock, KF
    Gibson, J
    Arthur, C
    To, LB
    Hughes, T
    Raunow, H
    INTERNAL MEDICINE JOURNAL, 2004, 34 (03) : 98 - 101
  • [28] EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GOODRICH, JM
    MORI, M
    GLEAVES, CA
    DUMOND, C
    CAYS, M
    EBELING, DF
    BUHLES, WC
    DEARMOND, B
    MEYERS, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23): : 1601 - 1607
  • [29] ABORTIVE HUMAN CYTOMEGALOVIRUS-INFECTION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    DEGAST, GC
    BOLAND, GJ
    VLIEGER, AM
    DEWEGER, RA
    VERDONCK, LF
    ZWAAN, FE
    JIWA, NM
    BONE MARROW TRANSPLANTATION, 1992, 9 (04) : 221 - 225
  • [30] Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
    Takehiko Mori
    Yoshinobu Aisa
    Takayuki Shimizu
    Tomonori Nakazato
    Rie Yamazaki
    Yasuo Ikeda
    Shinichiro Okamoto
    International Journal of Hematology, 2006, 83 : 266 - 270
12345